- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01625325
Identification and Characterization of Youth With Extreme Obesity (YES)
Medical and Psychosocial Implications of Adolescent Extreme Obesity - Acceptance and Effects of Structured Care Study, Subproject 1
While obese and extremely obese youth are at increased risk of health complications, especially the extremely obese group rarely seek medical care. One of the underlying reasons might be the lack of adequate treatment options. This study is a subproject of the "Medical and psychosocial implications of adolescent extreme obesity - acceptance and effects of structured care study", short: "Youth with Extreme obesity Study (YES)", which aims at improving the medical care and social support structures for youth with obesity and extreme obesity in Germany. In this subproject, information on the causes and consequences of extreme obesity will be gathered via questionnaires and medical examinations.
Obese youth and young adults (BMI ≥ 30kg/m2) between the ages of 14 and 24.9 years (initially up to 21 years) are eligible to participate. Participants will be asked to complete a series of questionnaires on their general health, psychosocial situation and wellbeing in 2-3 sessions. They will be offered a thorough medical examination comprising a general check-up, a fasting blood draw and oral glucose tolerance test, a focused orthopaedic examination, a sleep apnea screening, and an ultrasound of the liver. The aim of the study is to elicit the acceptance of diagnostic and therapeutic procedures, and to assess the frequency of co-morbidities in obese and extremely obese youth. This knowledge will optimize medical treatment and support options. Interested participants will be invited to participate in further steps of YES, which entail medical care and psycho-social support.
Study Overview
Status
Conditions
Detailed Description
In this multicenter study, we aim to recruit adolescents from various medical and non-medical settings and examine their acceptance of diagnostic and subsequent treatment procedures. We will compare the prevalence rates and severity of co-morbidities between adolescents with extreme obesity (BMI ≥35kg/m2)and those with less severe obesity (BMI 30-34.9kg/m2). This project is part of the "Medical and psychosocial implications of adolescent extreme obesity - acceptance and effects of structured care study", short: "Youth with extreme obesity Study (YES)", which also comprises a randomized controlled trial to investigate a novel intervention targeted at improving quality of life and social functioning of extremely obese adolescents, a structured prospective evaluation of adolescent bariatric surgery, and economic assessments of the financial burden of extreme adolescent obesity on the healthcare system.
Based on the current state of knowledge, we have formulated the following hypotheses in regards to baseline characteristics:
- The prevalence of somatic, psychiatric and psycho-social co-morbidities is higher, and health related quality of life is lower in extremely obese youth compared to the control group.
- The prevalence of somatic co-morbidities is equal in treatment-seeking and non treatment-seeking youth.
- The prevalence of psychiatric co-morbidities is higher and health related quality of life is lower in treatment-seeking compared to non treatment-seeking youth.
- The acceptance of diagnostic and therapeutic procedures is lower in extremely obese youth compared to the control group.
- The acceptance of diagnostic and therapeutic procedures is lower in non treatment-seeking- compared to treatment-seeking youth.
- Socio-economic status, intelligence and educational status are predictors of treatment seeking behaviour and of the acceptance of diagnostic and therapeutic procedures.
The five participating university centers are distributed across 4 geographic regions in the North (Berlin), in the West (Essen/Datteln), in the East (Leipzig) and in the South (Ulm) of Germany, and will therefore render data that are representative of Germany as a whole. We will recruit a total of 600 adolescents age 14 to 24.9 years (initial age 21 years, changed in an amendment in February 2013) with extreme obesity (BMI ≥ 35 kg/m2) and 600 adolescents with obesity (BMI 30-34.9 kg/m2) over a 24 months period. Baseline assessments include an array of standardized questionnaires and validated instruments to assess health, psycho-social situation, psychiatric co-morbidities and health related quality of life (in the amendment in February 2013, the scope of psychosocial questions was reduced), as well as a physical examination, laboratory tests, liver ultrasound, and screenings for orthopedic co-morbidities and sleep apnea. Subjects who participate in the baseline examination will be invited to participate in the subsequent components of YES.
The project will reveal comorbidity rates and psycho-social situation, and demonstrate the acceptance and outcomes of a structured healthcare program for adolescents with extreme obesity. The planned subsequent longitudinal study will provide unique information on the medical and psychosocial development of adolescents with extreme obesity in Germany.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Berlin, Germany, 13353
- Ambulatory Obesity Program, Charité University, Berlin
-
Datteln, Germany
- Vestische Kinderklinik, University of Witten/Herdecke
-
Essen, Germany, 45147
- University Duisburg-Essen
-
Leipzig, Germany, 04103
- University Hospital Leipzig
-
Ulm, Germany, 89075
- Dept for Pediatrics and Adolescent Medicine, University of Ulm: Interdisciplinary obesity clinic
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- BMI ≥30kg/m2
- sufficient German language skills
Exclusion Criteria:
- none
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
extremely obese
BMI ≥35kg/m2
|
obese
BMI 30-34.9kg/m2
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage of subjects that participate in the fasting blood draw
Time Frame: baseline
|
Subjects will be offered a diagnostic blood draw.
The percentage of subjects that undergo this blood draw will be calculated.
|
baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Predictors of the acceptance of the diagnostic procedures
Time Frame: baseline
|
baseline
|
|
Prevalence of obesity associated psychiatric co-morbidities
Time Frame: baseline
|
Co-morbidities will be assessed via validated patient questionnaires.
|
baseline
|
Percentage of patients that accept treatment of somatic co-morbidities
Time Frame: baselin
|
Appropriate medical treatment of the diagnosed somatic co-morbidities will be offered to all subjects.
The percentage of subjects who initiate such therapy will be calculated.
|
baselin
|
Predictors of acceptance of treatment of co-morbidities
Time Frame: baseline
|
baseline
|
|
Health related quality of life
Time Frame: baseline
|
assessed by validated questionnaire EQ5D
|
baseline
|
Socio-economic status
Time Frame: baseline
|
Assessed by standardized questionnaire.
|
baseline
|
Prevalence of obesity associated somatic co-morbidities
Time Frame: baseline
|
Co-morbidities will be assessed via standardized physical examination, laboratory and apparative tests, and standardized patient questionnaires.
|
baseline
|
Percentage of patients that accept treatment of psychiatric co-morbidities
Time Frame: baseline
|
Appropriate medical treatment of the diagnosed psychiatric co-morbidities will be offered to all subjects.
The percentage of subjects who initiate such therapy will be calculated.
|
baseline
|
Percentage of subjects that initiate a standardized low key intervention
Time Frame: baseline
|
All subjects will be offered the participation in a low key intervention as described in subproject two.
The percentage of patients that accept and initiate this intervention will be calculated.
|
baseline
|
Percentage of subjects that participate in diagnostic procedures.
Time Frame: baseline
|
Subjects will be offered a diagnostic liver ultrasound, sleep apnea screening, orthopedic screening, and an array of questionnaires to assess somatic- and psychiatric co-morbidities, psycho-social situation and health related quality of life.
The percentage of subjects that comply with these diagnostic procedures beyond the initial visit will be calculated.
|
baseline
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Chair: Martin Wabitsch, Prof. Dr. med., University of Ulm
- Study Director: Anja Moss, Dr. biol. hum., University of Ulm
- Study Director: Belinda S Lennerz, Dr. med., University of Ulm
- Study Director: Julia von Schnurbein, Dr. med., University of Ulm
Publications and helpful links
General Publications
- Wabitsch M, Moss A, Reinehr T, Wiegand S, Kiess W, Scherag A, Holl R, Holle R, Hebebrand J. Medical and psychosocial implications of adolescent extreme obesity - acceptance and effects of structured care, short: Youth with Extreme Obesity Study (YES). BMC Public Health. 2013 Aug 29;13:789. doi: 10.1186/1471-2458-13-789.
- Felix J, Stark R, Teuner C, Leidl R, Lennerz B, Brandt S, von Schnurbein J, Moss A, Bollow E, Sergeyev E, Muhlig Y, Wiegand S, Holl RW, Reinehr T, Kiess W, Scherag A, Hebebrand J, Wabitsch M, Holle R. Health related quality of life associated with extreme obesity in adolescents - results from the baseline evaluation of the YES-study. Health Qual Life Outcomes. 2020 Mar 5;18(1):58. doi: 10.1186/s12955-020-01309-z.
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- U1111-1131-4384a
- DRKS00004172 (Registry Identifier: Deutsches Register Klinischer Studien)
- 01GI1120A (Other Grant/Funding Number: Bundesministerium für Bildung und Forschung)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Fundació Sant Joan de DéuRecruitingObesity, Childhood | Obesity, AdolescentSpain
-
Consorcio Centro de Investigación Biomédica en...Maimónides Biomedical Research Institute of Córdoba; Instituto de Salud Carlos... and other collaboratorsActive, not recruiting
-
University of HoustonBaylor College of MedicineCompleted